Cargando…
IMT-1 A translational research for practical use of dendritic cell-based immunotherapy against malignant glioma
Background: Although a therapeutic effect of dendritic cell (DC)-based immunotherapy, a kind of regenerative medicine, has been recognized in various types of cancer including malignant glioma, it is still impractical because of several unsolved problems. This study is aimed to solve the problems in...
Autores principales: | Akasaki, Yasuharu, Takei, Jun, Yamamoto, Yohei, Tanaka, Toshihide, Kamata, Yuko, Murahashi, Mutsunori, Murayama, Yuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648218/ http://dx.doi.org/10.1093/noajnl/vdab159.042 |
Ejemplares similares
-
IMT-01 THERAPEUTIC EFFECT AGAINST LOWER GRADE GLIOMA INDUCED BY DENDRITIC CELL BASED IMMUNOTHERAPY
por: Akasaki, Yasuharu, et al.
Publicado: (2019) -
IMT-1 PROS AND CONS OF SURGICAL INTERVENTION FOR DIFFUSE MIDLINE GLIOMA AIMED AT DENDRITIC CELL IMMUNOTHERAPY
por: Akasaki, Yasuharu, et al.
Publicado: (2022) -
COT-08 Analysis of prognosis of biopsy/partial resection cases of malignant glioma
por: Yamamoto, Yohei, et al.
Publicado: (2020) -
Impact of Neoadjuvant Bevacizumab on Neuroradiographic Response and Histological Findings Related to Tumor Stemness and the Hypoxic Tumor Microenvironment in Glioblastoma: Paired Comparison Between Newly Diagnosed and Recurrent Glioblastomas
por: Takei, Jun, et al.
Publicado: (2022) -
Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma
por: Takei, Jun, et al.
Publicado: (2023)